Quick Answer
- A new 2026 mouse study suggests fat cells may keep a "memory" of obesity that leaves a hunger-boosting hormone called asprosin turned up, even after the extra weight is gone.
- In the main trial of semaglutide (Wegovy), people regained about two-thirds of the weight they'd lost within a year of stopping the drug.
- The fat cell finding hasn't been confirmed in people yet. But it fits a growing view that regaining weight is largely biology, not a lack of willpower. People who keep weight off long term tend to share a few habits.
One year after they stopped taking semaglutide, the people in a major clinical trial had regained about two-thirds of the weight they'd lost. They'd had lifestyle coaching during treatment, too. The weight came back anyway.
A new study in Cell Reports offers one possible reason. Researchers found that fat cells in mice seem to hold onto a kind of "memory" of obesity, one that keeps a hunger signal switched on long after the extra weight is gone. It's early, and it's in mice. But it adds fuel to an idea that's been gaining ground: regaining weight is often biology at work, not a character flaw.
Why Do People Regain Weight After Dieting?
Many people who lose weight struggle to keep it off. Researchers have spent years trying to work out why, and the answer is almost certainly a mix of things: hunger, habits, stress, sleep, the food around you. Biology is a big piece of that mix.
Here's the newer idea. Fat tissue isn't just a storage unit. It's an active organ that sends chemical signals to your brain, including signals about hunger. If obesity changes how those signals are set, losing the weight might not reset them right away.
What the New Study Found
A team at Case Western Reserve University studied fat cells grown in the lab and mice fed a high-fat diet. They focused on a hormone called asprosin. Your body normally releases asprosin during fasting, and it tells your brain you're hungry. Think of it as a "feed me" signal.
In obesity, levels of an inflammation-related signaling molecule called TGF-β1 go up. In the experiments, that molecule pushed fat cells to make more asprosin. Then came the surprising part. After the mice lost the extra weight, TGF-β1 went back to normal, but the fat cells kept making extra asprosin anyway. One of the researchers described it as a switch that got flipped and stayed that way.
The change was epigenetic. That means chemical tags on DNA that work like dimmer switches. They don't alter the genes themselves, but they can leave a gene turned up after the original trigger is gone.
The mice carrying this "memory" regained more weight when they went back to a high-fat diet. And when the researchers neutralized asprosin, the extra gain stopped in one of their weight-loss models.
The team also reported that the same signal can cross the placenta in pregnant mice and appeared to influence fat cells in their pups. They suggest that may help explain why obesity risk can run in families. That part is mouse research too, and it's a long way from anything doctors can use.
What This Study Can't Tell You
Animal research suggests a mechanism. It doesn't prove the same thing happens in your body. The researchers say their next step is to check whether this memory exists in human fat tissue and whether blocking it could help people keep weight off.
There's some earlier human evidence pointing the same direction. A 2024 study took fat tissue samples from people before and about two years after major weight loss. It found that obesity-related epigenetic changes were still there. That's intriguing, but it shows the marks persist. It doesn't prove they cause weight regain.
And there's no asprosin-blocking option for people. It's a possible future target, not something you can ask your doctor for. One study never settles a question like this, and mouse results often don't carry over to humans.
Do You Regain Weight After Stopping Ozempic?
Often, yes. The best evidence comes from the STEP 1 trial extension, which followed adults after they stopped semaglutide 2.4 mg, the dose sold as Wegovy. Over 68 weeks of treatment, those participants lost an average of 17.3% of their body weight. A year after stopping, they had regained 11.6 percentage points of it, about two-thirds. That left them roughly 5.6% below their starting weight. Heart and metabolic improvements, such as blood sugar and blood pressure readings, drifted back toward where they began.
Clinical trials indicate the pattern isn't unique to one drug. A separate withdrawal trial of tirzepatide (SURMOUNT-4) also found substantial regain after people stopped.
A few caveats apply. The extension analyses were exploratory, and the people in that year-long follow-up weren't getting active lifestyle support. Individual results vary a lot. And any decision about starting, switching, or stopping a GLP-1 medication belongs with the doctor who prescribes it.
For more on how these drugs work and what to expect, see our guides to GLP-1 weight loss drugs, compounded GLP-1 peptides, and muscle loss on GLP-1s. If you're already on one, our GLP-1 meal guide covers how to eat well while appetite is low.
What Research Says Helps People Keep Weight Off
The best-known data on this comes from the National Weight Control Registry, which tracks adults who lost at least 30 pounds and kept it off for a year or more. On average, members had lost about 70 pounds and held it for several years.
Their habits look a lot alike. Most report about an hour a day of moderate activity, with walking the most common. About three in four weigh themselves at least once a week, and most eat breakfast daily. Researchers also point to a consistent eating pattern across weekdays and weekends, and to catching small gains before they turn into bigger ones.
One honest limit: this is observational, self-reported data. People who succeed may differ from people who don't in ways the registry can't capture, so these habits are associations, not guarantees.
Some of those habits connect to topics we've covered. Fiber may help with fullness; our piece on how fiber influences the same gut-brain hunger signals that GLP-1 drugs target explains how. Protein plays a role too; see our deep dive on high-protein diets. For the bigger picture on slower, steadier loss, start with our guides to sustainable weight loss and resetting a sluggish metabolism.
Clinical Evidence at a Glance
| Claim | Evidence Level | What Research Suggests |
|---|---|---|
| Fat cells keep a hunger-hormone "memory" after weight loss | Animal and lab research (mice, 2026) | Asprosin stayed elevated after weight loss; neutralizing it stopped excess regain in one mouse model; not yet confirmed in people |
| Human fat tissue also retains obesity-related changes | Human fat biopsies plus mouse experiments (2024) | Epigenetic changes persisted about two years after major weight loss; doesn't prove they cause regain |
| Weight returns after stopping semaglutide | Randomized trial extension (STEP 1, 327 participants) | About two-thirds of lost weight regained within a year; exploratory analysis |
| People who keep weight off share certain habits | Observational registry (self-reported) | High daily activity, regular breakfast, frequent weighing; can't prove cause and effect |
The Bottom Line
The "obesity memory" idea is one of the more interesting explanations for why weight comes back, but right now it's a mouse finding. What the human data already show is simpler and sturdier: weight regain is common, it often follows stopping medication, and it isn't proof that someone failed. If you've lost weight, the research points to staying active, keeping a steady routine, and checking in with your weight often enough to catch small gains early.
Frequently Asked Questions
Why do I regain weight after dieting?
Several things play a part, including hunger signals, habits, stress, and sleep. New mouse research suggests fat cells may also hold a lasting "memory" of obesity that keeps a hunger hormone elevated, though that hasn't been confirmed in people.
Do fat cells remember being obese?
Animal research suggests they might. In mice, fat cells kept making extra asprosin, a hunger-boosting hormone, even after the animals lost weight. A 2024 study also found lasting epigenetic changes in human fat tissue two years after major weight loss, but it's not yet clear that these changes drive regain.
What is asprosin?
Asprosin is a hormone your body normally releases during fasting. It signals the brain that you're hungry. In the new mouse study, fat cells kept producing extra of it after weight loss.
Do you regain weight after stopping Ozempic?
Often, yes. In the STEP 1 trial extension, people regained about two-thirds of the weight they'd lost within a year of stopping semaglutide. Talk with your prescribing doctor before changing or stopping any GLP-1 medication.
Is weight regain a lack of willpower?
Research increasingly points the other way. Biology, including hunger hormones, appears to play a major role, which is why many clinicians now describe obesity as a long-term condition rather than a one-time fix.
How can I keep weight off?
People in the National Weight Control Registry commonly report about an hour a day of moderate activity, eating breakfast regularly, weighing themselves often, and keeping a consistent eating pattern. These are observed habits, not guarantees.
Is there a drug that blocks asprosin?
Not one available for weight management. Blocking the asprosin pathway has only been tested in animals so far.
References
- Kim et al. Adipose TGFβ-asprosin memory promotes obesity relapse and offspring obesity susceptibility. Cell Reports, 2026;45(8):117809. View summary
- Obesity's Epigenetic "Memory" Fuels Weight Regain. Medscape, 2026. View article
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022. View study
- Adipose tissue retains an epigenetic memory of obesity after weight loss (2024 human fat-tissue study, summary). View summary
- Wing RR, Phelan S. Long-term weight loss maintenance. American Journal of Clinical Nutrition, 2005. View study
The Health Findings Lab Research Team is a dedicated group of health writers, data analysts, and editorial reviewers. Operating under strict, evidence-based editorial guidelines, the team synthesizes peer-reviewed clinical literature to provide objective insights. Our collaborative approach ensures that every review prioritizes verifiable efficacy and manufacturing transparency over marketing hyperbole.
